GlassScriptPhysician profile
Ann Arackal
NPI 1962852129
$1,892.00
in general payments reported to CMS, 2019-2025
22 companies · $639 in 2025
The $639 reported for 2025 was more than what 78% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $290 · 2020: $142 · 2022: $106 · 2023: $215 · 2024: $501 · 2025: $639.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,354.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,354.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $272.85 | 2019-2025 | Airsupra, Breztri |
| Abbott Laboratories | $174.69 | 2023-2024 | Proclaim, Freestyle Libre 3 |
| Pfizer INC. | $162.94 | 2024-2025 | |
| Novo Nordisk INC | $143.00 | 2019-2025 | Wegovy |
| Thd America, INC. | $133.07 | 2023 | |
| Lilly USA, LLC | $129.58 | 2020-2025 | Zepbound, Jardiance, Mounjaro |
| Depuy Synthes Sales INC. | $124.99 | 2020 | |
| Astellas Pharma US INC | $124.79 | 2025 | Veozah |
| Gilead Sciences, INC. | $124.24 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $99.72 | 2019 | |
| Merck Sharp & Dohme LLC | $64.50 | 2019-2025 | Capvaxive |
| Kowa Pharmaceuticals America, INC. | $53.10 | 2024-2025 | Zoryve |
| Exact Sciences Corporation | $47.87 | 2025 | Cologuard Collection Kit |
| Abbvie INC. | $42.39 | 2025 | |
| Corcept Therapeutics | $34.10 | 2025 | Korlym |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dynavax Technologies Corporation | $27.11 | 2022 | |
| Amgen INC. | $26.63 | 2022 | |
| Eisai INC. | $26.35 | 2024 | |
| Dexcom, INC. | $22.38 | 2023 | Dexcom G6 Transmitter |
| Avvisto Therapeutics, LLC | $20.17 | 2024 | Cycloset |
| Seqirus USA INC | $20.00 | 2019 | |
| Phadia US INC. | $17.53 | 2025 | Immunocap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ann Arackal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.